New pill offers hope to patients with aggressive form of breast cancer
SINGAPORE – An orally consumed anti-cancer drug known as Bexarotene offers new hope to patients with triple-negative breast cancer (TNBC) – an aggressive form of breast cancer that appears more frequently among women below 40. This drug has been found to be able to tame highly aggressive and invasive breast cancer cells by converting them... » read more